Literature DB >> 10385598

Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth-muscle cells: species variation.

K B Jourdan1, T W Evans, N J Lamb, P Goldstraw, J A Mitchell.   

Abstract

Pulmonary hypertension is characterized by hypertrophy and hyperplasia of vascular smooth muscle occurring via an unknown mechanism. Cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) are expressed under inflammatory conditions and produce mediators that regulate growth in some tissues. We have therefore addressed the question of COX-2 and iNOS involvement in proliferation of human and rat pulmonary artery (PA) smooth-muscle cells (SMC). Interleukin (IL)-1beta suppressed proliferation of both human and rat PA SMC. Moreover, IL-1beta induced COX-2 expression in both cell types. By contrast, IL-1beta stimulated the expression of iNOS protein in rat cells only. COX-2 induced in human cells inhibited proliferation, whereas COX-2 products in rat cells were without affect. However, iNOS activity in rat cells suppressed their proliferation. We conclude that human and rat evolution has diverged such that COX-2 and iNOS, although induced by the same mediator, have different levels of activity and functions in the two species. In humans, induction of COX-2 during pulmonary hypertension may be beneficial for long-term treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385598     DOI: 10.1165/ajrcmb.21.1.3502

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

1.  Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells.

Authors:  Louis G Chicoine; Louis G Chicione; Michael R Stenger; Hongmei Cui; Andrea Calvert; Rebecca J Evans; B Keith English; Yusen Liu; Leif D Nelin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

2.  Inhibition of cyclooxygenase-2 and inducible nitric oxide synthase by silymarin in proliferating mesenchymal stem cells: comparison with glutathione modifiers.

Authors:  Hamidreza Ahmadi-Ashtiani; Abdolamir Allameh; Hosein Rastegar; Masoud Soleimani; Elham Barkhordari
Journal:  J Nat Med       Date:  2011-06-28       Impact factor: 2.343

3.  Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Dhara Patel; Anand Lakhkar; Michael S Wolin
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Molecular mechanisms of pulmonary arterial remodeling.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  Mol Med       Date:  2014-04-22       Impact factor: 6.354

5.  Role of prostacyclin in pulmonary hypertension.

Authors:  Jane A Mitchell; Blerina Ahmetaj-Shala; Nicholas S Kirkby; William R Wright; Louise S Mackenzie; Daniel M Reed; Nura Mohamed
Journal:  Glob Cardiol Sci Pract       Date:  2014-12-31

6.  Anti-inflammatory and vasoprotective activity of a retroviral-derived peptide, homologous to human endogenous retroviruses: endothelial cell effects.

Authors:  George J Cianciolo; Salvatore V Pizzo
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.